Trials / Completed
CompletedNCT01952041
A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was a 2-arm randomized control trial (RCT) designed to test a multi-modal smartphone data collection system that provided mobile monitoring of schizophrenia to detect early signs of relapse. The RCT compared an arm with participants who received treatment as usual with an arm that received the smartphone system for a year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Device: Smartphone | |
| BEHAVIORAL | Treatment as usual |
Timeline
- Start date
- 2015-03-13
- Primary completion
- 2017-08-07
- Completion
- 2017-08-07
- First posted
- 2013-09-27
- Last updated
- 2019-06-21
- Results posted
- 2019-06-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01952041. Inclusion in this directory is not an endorsement.